BNP Paribas Bonus Zert AMD 27.03..../ DE000PG1D131 /
| 2024-06-24 9:03:01 AM | Chg.-0.40 | Bid10:00:39 PM | Ask10:00:39 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 139.02EUR | -0.29% | - Bid Size: - |
- Ask Size: - |
Advanced Micro Devic... | - USD | 2025-03-27 | Call |
GlobeNewswire
06-24
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
06-19
AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire
06-18
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
06-17
D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
GlobeNewswire
06-14
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
06-13
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
06-13
Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire
06-12
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
06-12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
06-12
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire
06-11
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
06-10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
06-08
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
